Health ❯Healthcare

Chronic Diseases

Diabetes Obesity Type 2 Diabetes Kidney Disease Heart Disease Dementia Nutrition Hypertension Chronic Kidney Disease Public Health Respiratory Diseases Cancer Cardiovascular Health Diabetes Management Cardiovascular Diseases Diabetes Complications Chronic Obstructive Pulmonary Disease Cardiovascular Disease Disease Prevention HIV/AIDS Fibrosis Stress-Related Disorders Movement Disorders Diabetes Treatment Musculoskeletal Disorders Epidemiology Cancer Risk Vaccine Safety Cancer Care Research Funding Obesity Management Heart Health Health Regulations Myocardial Infarction Preventive Care Inflammation Neurodegenerative Diseases Liver Disease Child Health Financial Support Vaccination Childhood Diseases HIV Treatment Scientific Research Multiple Sclerosis Metabolic Disorders Inflammatory Bowel Disease Acne Inversa Neurological Disorders Heart Failure Allergies Inflammatory Diseases Bone Health COPD Asthma Treatment Costs Chronic Obstructive Pulmonary Disease (COPD) Ulcerative Colitis Health Insurance Type 1 Diabetes Obesity-Related Health Issues Autoimmune Diseases

Dr. Mehmet Oz Confirmed as CMS Administrator in Partisan Senate Vote

MIT Researchers Unveil Injectable Microcrystal System for Long-Term Drug Delivery

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Berlin Workers Report 21 Sick Days Annually, Driven by Mental and Musculoskeletal Illnesses

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

FDA Approves First Clinical Trials for Pig Kidney Transplants in Humans

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Study Reveals Broad Benefits and Risks of GLP-1 Weight-Loss Drugs

Study Links Common Medications to Reduced Dementia Risk

Study Maps Broad Health Impacts of Popular GLP-1 Weight-Loss Drugs

Study Highlights Benefits and Risks of Popular Weight-Loss Drugs

GLP-1 Drugs Revolutionize Prescriptions and Broader Health Applications

U.S. Leads World in Years Spent in Poor Health Despite Longer Lifespans

Heart Disease and Cancer Lead Causes of Death in Berlin and Brandenburg in 2023

New Injection Shows Promise as First Major Asthma and COPD Treatment Breakthrough in 50 Years

First New Asthma and COPD Treatment in 50 Years Shows Promise

Diabetes and Obesity Drugs Found to Protect Kidney Health

Trump Nominates Former Congressman Dave Weldon as CDC Director

32 U.S. Students Awarded 2025 Rhodes Scholarships

RFK Jr. Confident in Securing White House Role Under Trump

Cost and Efficacy Concerns Arise for GLP-1 Weight Loss Drugs

Ozempic May Lower Alzheimer's Risk in Type 2 Diabetics, Study Finds

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks

FDA Approves Vyalev for Advanced Parkinson's Disease Treatment

Caffeine Linked to Improved Vascular Health in Lupus Patients

Novo Nordisk Launches Wegovy in France Without Reimbursement

Boehringer Ingelheim's Survodutide Wins FDA Breakthrough Status for MASH Treatment

FDA Approves Regeneron-Sanofi's Dupixent for COPD Treatment

Semaglutide Shows Promise in Reducing Opioid Overdose Risk, Study Finds

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

Weekly Insulin Shots Match Daily Injections in Diabetes Management

Updated Covid-19 Vaccines No Longer Free for Uninsured in US

New Studies Confirm Safety of Semaglutide for Mental Health

Semaglutide Shows Potential to Slow Aging and Reduce Mortality Rates

Blood Tests Identify Women's Heart Disease Risk Decades in Advance

AI Tool Optimise Identifies High-Risk Heart Patients

New Smart Mask Monitors Respiratory Health Through Breath Analysis

Type 2 Diabetes Drug Shows Potential to Lower Dementia Risk by 35%

Healthy Lifestyle May Mitigate Diabetes-Induced Brain Aging

Eli Lilly's Tirzepatide Shows 94% Reduction in Diabetes Risk

Study Reveals High Prevalence of Lung Nodules in Non-Smokers

Researchers Develop 'Smart Insulin' for Improved Diabetes Management

New Osteoporosis Drug Approved for Postmenopausal Women in England

NHS 'Soup and Shake' Diet Shows Promise in Reversing Type 2 Diabetes

Mast Cells' Unexpected Role in Allergic Reactions

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

Semaglutide Drugs Show Potential Beyond Weight Loss

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline

UK Approves Wegovy for Reducing Heart Risks in Overweight Patients

Pharmacists and Community Health Workers Lead in Hypertension Control

Ozempic's Expanding Role: Beyond Diabetes and Weight Loss